{"id":"https://openalex.org/W2805583568","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps1104","title":"Palbociclib after CDK and endocrine therapy (PACE): A randomized phase II study of fulvestrant, palbociclib, and avelumab for endocrine pre-treated ER+/HER2- metastatic breast cancer.","display_name":"Palbociclib after CDK and endocrine therapy (PACE): A randomized phase II study of fulvestrant, palbociclib, and avelumab for endocrine pre-treated ER+/HER2- metastatic breast cancer.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2805583568","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps1104","mag":"2805583568"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.tps1104","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps1104","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps1104","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111775802","display_name":"EL Mayer","orcid":"https://orcid.org/0000-0001-5430-8957","observed_orcids":["https://orcid.org/0000-0001-5430-8957"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erica L. Mayer","raw_affiliation_strings":["Dana-Farber Cancer Institute, Waban, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Waban, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025351031","display_name":"Seth Andrew Wander","orcid":"https://orcid.org/0000-0002-4127-4708","observed_orcids":["https://orcid.org/0000-0002-4127-4708"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seth Andrew Wander","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017334876","display_name":"Meredith M. Regan","orcid":"https://orcid.org/0000-0002-2428-6109","observed_orcids":["https://orcid.org/0000-0002-2428-6109"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meredith M. Regan","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005537242","display_name":"Angela M. DeMichele","orcid":"https://orcid.org/0000-0003-1297-4251","observed_orcids":["https://orcid.org/0000-0003-1297-4251"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela DeMichele","raw_affiliation_strings":["Penn Medicine Abramson Cancer Center, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Penn Medicine Abramson Cancer Center, Philadelphia, PA;","institution_ids":["https://openalex.org/I4390039297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046549002","display_name":"Andres Forero","orcid":"https://orcid.org/0000-0001-8904-2626","observed_orcids":["https://orcid.org/0000-0001-8904-2626"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andres Forero-Torres","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072850149","display_name":"Mothaffar Fahed Rimawi","orcid":"https://orcid.org/0000-0002-4284-5656","observed_orcids":["https://orcid.org/0000-0002-4284-5656"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mothaffar F. Rimawi","raw_affiliation_strings":["Baylor College of Medicine, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine, Houston, TX;","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035849162","display_name":"Cynthia X. Ma","orcid":"https://orcid.org/0000-0002-8156-7492","observed_orcids":["https://orcid.org/0000-0002-8156-7492"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia X. Ma","raw_affiliation_strings":["Washington University School of Medicine in St. Louis, St. Louis, MO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine in St. Louis, St. Louis, MO;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032987754","display_name":"Massimo Cristofanilli","orcid":"https://orcid.org/0000-0002-4194-7175","observed_orcids":["https://orcid.org/0000-0002-4194-7175"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I4390039227","display_name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","ror":"https://ror.org/02p4far57","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210147348","https://openalex.org/I4390039227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Massimo Cristofanilli","raw_affiliation_strings":["Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL;","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I4390039227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013557141","display_name":"Carey K. Anders","orcid":"https://orcid.org/0000-0001-9165-4074","observed_orcids":["https://orcid.org/0000-0001-9165-4074"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carey K. Anders","raw_affiliation_strings":["University of North Carolina, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047768231","display_name":"Cynthia Huang Bartlett","orcid":"https://orcid.org/0000-0003-2003-2213","observed_orcids":["https://orcid.org/0000-0003-2003-2213"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia Huang Bartlett","raw_affiliation_strings":["Pfizer Inc, Collegeville, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Collegeville, PA;","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070245248","display_name":"Eric P. Winer","orcid":"https://orcid.org/0000-0002-8819-1723","observed_orcids":["https://orcid.org/0000-0002-8819-1723"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric P. Winer","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055301443","display_name":"Harold J. Burstein","orcid":"https://orcid.org/0000-0003-1963-8162","observed_orcids":["https://orcid.org/0000-0003-1963-8162"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harold J. Burstein","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"TPS1104","last_page":"TPS1104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9559999704360962},{"id":"https://openalex.org/keywords/cdk4-6-inhibition","display_name":"CDK4/6 inhibition","score":0.8009999990463257},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.9110000133514404},{"id":"https://openalex.org/keywords/avelumab","display_name":"avelumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.7979999780654907},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.7269999980926514},{"id":"https://openalex.org/keywords/hr-her2-metastatic-breast-cancer","display_name":"HR+/HER2- metastatic breast cancer","score":0.8650000095367432},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7820000052452087},{"id":"https://openalex.org/keywords/cdk4-6-inhibitor-resistance","display_name":"CDK4/6 inhibitor resistance","score":0.781000018119812},{"id":"https://openalex.org/keywords/pi3k-mutations","display_name":"PI3K mutations","score":0.9589999914169312},{"id":"https://openalex.org/keywords/ctdna","display_name":"ctDNA","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.9699227809906006},{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9549636840820312},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8629948496818542},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6970614194869995},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6414243578910828},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6124337315559387},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5135164856910706},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4667964577674866},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4242391288280487},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.3401572108268738},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32606393098831177},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.1972542703151703},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.14352265000343323},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.13289949297904968}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.tps1104","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps1104","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps1104","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8500000238418579}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4220872882","https://openalex.org/W2754339892","https://openalex.org/W2751810360","https://openalex.org/W3203690439","https://openalex.org/W4295817034","https://openalex.org/W4282924254","https://openalex.org/W4323050407","https://openalex.org/W3093743109","https://openalex.org/W2296942186","https://openalex.org/W3031130887"],"abstract_inverted_index":{"TPS1104":[0],"Background:":[1],"CDK4/6":[2,113],"inhibition":[3,114],"(CDK4/6i)":[4],"has":[5,109],"a":[6,25,121],"well-established":[7],"role":[8],"in":[9,31,40,101,190],"the":[10,41,166],"management":[11],"of":[12,24,37,47,62,67,99,142,168,188,200,214,221,251,280,285],"hormone":[13],"receptor":[14],"positive/HER2":[15],"negative":[16],"(HR+/HER2-)":[17],"metastatic":[18],"breast":[19],"cancer":[20],"(MBC).":[21],"The":[22,89,156],"addition":[23],"CDK4/6i":[26,50,63,242],"to":[27,35,49,94,129,160,225,237],"endocrine":[28,116],"therapy":[29,79,100,226],"(ET)":[30],"HR+/HER2-":[32,232],"MBC":[33,107],"leads":[34],"prolongation":[36],"progression-free":[38,162],"survival":[39,163],"first-line":[42],"and":[43,55,83,115,147,154,170,181,203,205,217,223,238,243,258,276],"pre-treated":[44],"settings.":[45],"Mechanisms":[46],"resistance":[48,224],"are":[51],"not":[52,58],"well":[53],"described,":[54],"it":[56],"is":[57,120,159,227,288],"known":[59],"if":[60],"continuation":[61],"with":[64,80,104,165,234,254],"subsequent":[65,97,239,256],"lines":[66,279],"ET":[68,72],"improves":[69],"outcomes":[70,189],"over":[71],"alone.":[73],"Further,":[74],"preclinical":[75],"data":[76],"suggest":[77],"combination":[78,167],"ET,":[81,244,275],"CDK4/6i,":[82],"anti-PDL1":[84],"may":[85,270],"provide":[86],"synergistic":[87],"efficacy.":[88],"PACE":[90,119],"trial":[91,125],"was":[92],"designed":[93],"determine":[95],"optimal":[96],"line":[98],"patients":[102,287],"(pts)":[103],"HR+":[105],"/HER2-":[106],"that":[108],"progressed":[110],"despite":[111],"prior":[112,235,252,263,274,278],"therapy.":[117],"Methods:":[118],"multicenter":[122],"phase":[123],"II":[124],"randomizing":[126],"pts":[127,230],"1:2:1":[128],"Arm":[130,144,150],"A:":[131],"fulvestrant":[132,146,169,173],"alone":[133],"(with":[134],"option":[135],"for":[136,184,219,267],"palbociclib":[137,171],"monotherapy":[138],"crossover":[139],"at":[140,247],"time":[141],"progression);":[143],"B:":[145],"palbociclib;":[148],"or":[149],"C:":[151],"fulvestrant,":[152],"palbociclib,":[153],"avelumab.":[155],"primary":[157],"objective":[158],"evaluate":[161],"(PFS)":[164],"vs.":[172],"alone;":[174],"secondary":[175],"objectives":[176],"include":[177],"overall":[178],"response":[179,222,236],"(OR)":[180],"PFS":[182],"comparisons":[183],"other":[185],"arms;":[186],"assessment":[187],"predefined":[191],"molecular":[192],"subgroups":[193],"including":[194],"ESR":[195],"mutation,":[196,198],"PI3K":[197],"loss":[199],"Rb;":[201],"safety":[202],"tolerability;":[204],"comparing":[206],"OR":[207],"by":[208],"RECIST":[209],"vs":[210],"irRECIST.":[211],"Extensive":[212],"analysis":[213],"tissue,":[215],"ctDNA,":[216],"CTC":[218],"markers":[220],"planned.":[228,289],"Eligible":[229],"have":[231,271],"MBC,":[233],"progression":[240],"on":[241],"defined":[245],"as":[246],"least":[248],"6":[249],"months":[250],"treatment,":[253],"confirmed":[255],"progression,":[257],"no":[259],"more":[260],"than":[261],"one":[262],"P":[264],"dose":[265],"reduction":[266],"toxicity.":[268],"Pts":[269],"had":[272],"1-2":[273],"0-1":[277],"chemotherapy.":[281],"A":[282],"sample":[283],"size":[284],"220":[286],"NCT03147287.":[290]},"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}